Advertisement
Canada markets close in 1 hour 12 minutes

  • S&P/TSX

    22,171.07
    -72.95 (-0.33%)
     

  • S&P 500

    5,562.46
    +25.44 (+0.46%)
     

  • DOW

    39,361.89
    +53.89 (+0.14%)
     

  • CAD/USD

    0.7338
    -0.0009 (-0.12%)
     

  • CRUDE OIL

    83.29
    -0.59 (-0.70%)
     

  • Bitcoin CAD

    77,120.41
    -2,099.83 (-2.65%)
     

  • CMC Crypto 200

    1,174.51
    -34.18 (-2.83%)
     

  • GOLD FUTURES

    2,398.50
    +29.10 (+1.23%)
     

  • RUSSELL 2000

    2,021.96
    -14.66 (-0.72%)
     

  • 10-Yr Bond

    4.2780
    -0.0770 (-1.77%)
     

  • NASDAQ

    18,336.62
    +148.32 (+0.82%)
     

  • VOLATILITY

    12.61
    +0.35 (+2.85%)
     

  • FTSE

    8,203.93
    -37.33 (-0.45%)
     

  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     

  • CAD/EUR

    0.6768
    -0.0024 (-0.35%)
     
MARKETS LIVE BLOG:

S&P 500, NASDAQ BUILD ON RECORDS AS U.S. JOBS DATA FUEL BETS FOR SEPT. RATE CUT

Bitcoin slides as the stock market reaches higher

Pacific Biosciences: Q1 Earnings Snapshot

Associated Press Finance
·1 min read

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $78.2 million in its first quarter.

On a per-share basis, the Menlo Park, California-based company said it had a loss of 29 cents. Losses, adjusted for one-time gains and costs, were 26 cents per share.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 26 cents per share.

The maker of genetic analysis technology posted revenue of $38.8 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PACB at https://www.zacks.com/ap/PACB